Cell line · CVCL_0255
EL4
Cancer cell line, Mus musculus. Mouse precursor T cell lymphoblastic lymphoma/leukemia. 45 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. EL4. Cell lines, record CVCL_0255. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0255
On this page
Cell line
As Cellosaurus gives it.
- Name
- EL4
- Accession
- CVCL_0255
- RRID
- RRID:CVCL_0255
- Synonyms
- EL-4, EL 4, E.L.4, EL-4 Male
- Species
- Mus musculus (Mouse)
- Sex
- Sex unspecified
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Mouse precursor T cell lymphoblastic lymphoma/leukemia (NCIt C21925)
- Derived from
- Ascites (in situ)
- Cell type
- T-cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers45
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Plasma Membrane Lipid Asymmetry Dynamically Regulates Passive Diffusion. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Actin conformation dynamics precede force generation in cytotoxic T lymphocytes. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Selective Targeting of Tip Endothelial Cells as a Therapeutic Strategy for Tumor Angiogenesis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FAPα+ Macrophages Orchestrate Immune Evasion in Multiple Myeloma by Dual Regulation of PD-L1 and T Cell Senescence. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PD-1 suppresses CAR signaling by forming the inhibitory signalosome colocalizing to CAR microclusters. | Commun Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 45
See all 45 papersRelatives21
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | E.G7-OVA | CVCL_3505 | Cell lines | |
| Derived from it | EL-4 6.1 | CVCL_A0DM | Cell lines | |
| Derived from it | EL-4/cCD20 | CVCL_E3E7 | Cell lines | |
| Derived from it | EL-4ad | CVCL_8603 | Cell lines | |
| Derived from it | EL4-B7-2 | CVCL_B6PH | Cell lines | |
| Derived from it | EL4-Luc2 [ATCC] | CVCL_A4BN | Cell lines | |
| Derived from it | EL4-TK | CVCL_F943 | Cell lines | |
| Derived from it | EL4-Zbtb1 KO | CVCL_A0PX | Cell lines | |
| Derived from it | EL4-hCD19-LZ | CVCL_E8H0 | Cell lines | |
| Derived from it | EL4-hCD20-LZ | CVCL_E6BL | Cell lines |
1 to 10 of 21
See all 21 relativesCell banks15
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | TIB-39 | ATCC | |
| BCRC | 60179 | BCRC | |
| CCTCC | GDC0136 | Cellosaurus | |
| CLS | 300653 | CLS | |
| DSMZ | ACC-831 | DSMZ | |
| ECACC | 85023105 | ECACC | |
| Hysigen | TCM-C727 | Hysigen | |
| JCRB | IFO50027 | Discontinued | Cellosaurus |
| JCRB | JCRB1350 | JCRB | |
| KCB | KCB 2013027YJ | Cellosaurus |
1 to 10 of 15
See all 15 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0255
GET https://conductscience.org/api/cell-lines/v1/CVCL_0255/papers?page=2